Diese Veranstaltung hat bereits stattgefunden.

The EUGOGO 20th Anniversary Meeting

56125 Pisa, Italien
Symposium

The EUGOGO 20th Anniversary Meeting

International Symposium on Graves' Orbitopathy

Datum:
07.11.2019, 12:00 - 09.11.2019, 13:00
Veranstalter:
European Group on Graves` Orbitopathy (EUGOGO)
Kurzbeschreibung:
The 20th EUGOGO Anniversary International Meeting and Graves’ Orbitopathy Conference will be held this year in pisa from November the 7th until November the 9th at the Camera di Commercio and generally treated Greaves' Orbitopathy.
Fortbildungspunkte: 

Fachärzte

Max. Teilnehmer: unbegrenzt
Gebühren ab: 450,00 EUR

Hinweis:
Price for EUGOGO members : € 350,00

ACCOMPANYING PERSONS
(includes Welcome Reception at the Congress Venue and Congress Dinner) - € 160,00

für Referenten

Abstract: 10.08.2019
Hinweis:
Abstract submission for oral and poster presentations are welcome

- At least one author per abstract must be registered prior to abstract submission. In all other cases abstracts will be rejected

-Acceptance or rejection will be confirmed by August 30th

-Abstract should be no longer than 300 words, and should include Title, First and Last name of the authors separated by commas, affiliation/s of the authors

-No images or pictures are allowed

-Abstracts should be organized into the following sections: Background, Methods, Results, Conclusions.
Bemerkungen:
Diese Veranstaltung findet unregelmäßig statt und bietet Fortbildungsmöglichkeiten für Fachärzte.
Veranstaltungsnummer: 32164
Gebühren ab: ab 450,00
verfügbare Plätze: unbegrenzt
Sprache: Englisch
 
Abstract: 10.08.2019
Vom Veranstalter gemeldetes Programm:

 

  SCIENTIFIC  PROGRAM Thursday, November the 7th, 2019
12:00 - 13:00 Registration Opening Ceremony
13:00 - 13:15 Opening Ceremony
13:20 - 13:30 Tomb of Sarteano: the first GO painting in history
  Lelio Baldeschi (Brussels), Maurizio Martinelli (Firenze)
13:30 - 13:50 Mark Prummel memorial lecture
  Chairperson: Claudio Marcocci (Pisa)
  EUGOGO achievements over 20 years - Wilmar Wiersinga (Amsterdam)
13:55 - 15:35 Symposium 1: the lmmunopathogenesis of GO in 2019
  Chairpersons: Paul Banga (London), Marvin Gershengorn (Bethesda) 
13:55 - 14:15  Genetics and epigenetics of GO - Simon Pearce (Newcastle upon Tyne)
14:15 - 14:35  Role of fibrocytes in GO - Terry Smith (Ann Arbor)
14:35 - 14:55 Overview of the immune response in GO - Wilfern A.  Dik (Amsterdam)
14:55 - 15:15 The microbioma in Graves' disease and GO - Marian Ludgate (Cardiff) 
15:15 - 15:35 Graves' disease and GO following immune reconstitution Ilaria Muller (Cardiff) 
15:40 - 16:40 Oral Presentations 1
  Chairpersons: Nicola Curro (Milan),  Michele Marino (Pisa)
16:40 - 17:00 Coffee Break
17:00 - 18:40 Symposium 2: diagnostic issues on GO phenotypes
   Chairpersons: Chistoph Hintschich (Munich), Ray Douglas (Los Angeles) 
17:00 - 17:20  Unilateral, hypothyroid and euthyroid GO - Anja Eckstein (Essen)
17:20 - 17:40  Orbital volumetry and its significance - Wilmar Wiersinga (Amsterdam)
17:40 - 18:00 IgG4-related disease, the inflammatory neophyte in the orbit /lse Mombaerts (Leuven)
18:00 - 18:20 Differential diagnosis of GO: the importance of multidisciplinarity and specialized centers - Lelio Baldeschi (Brussels)
18:20 - 18:40 Diagnostic criteria and management of optic neuropathy - Antonella Boschi (Brussels)
18:45 - 19:05 George von Arx memorial lecture
  Chairperson: Lelio Baldeschi (Brussels)
  The importance of the ophthalmologist and of the joint clinic in GO / Nicole Fichter (Olfen)
19:05 - 20:00 Welcome  Cocktail

 

 

  SCIENTIFIC  PROGRAM Friday, November the 8th, 2019
8:30 - 8:50 Aldo Pinchera memorial lecture
  Chairperson: Paolo Vitti (Pisa)
  Epidemiology and secular trends of GO - Petros Perros (Newcastle upon Tyne)
8:55 - 9:15 Symposium 3: anlmal models of GD and GO
  Chairpersons:  Marian Ludgate (Cardiff),  Gerd Krause (Berlin)
8:55 - 9:15 Epitope peptides derived from the TSH receptor as an effective treatment in a mouse model of Graves' disease and GO - Martin Ungerer (Bavaria)
  The "English" model - Paul Banga (London)
9:35 - 9:55 The "German" model - Utta Berchner-Pfannshmidt (Essen)
10:00 - 11:00 Oral Presentations 2
  Chairpersons: Katharina Ponto (Mainz),  Milos iarkovic (Beigrade)
11:00 - 11:20 Coffee Break
11:20 - 12:40 Symposium 4: ophthalmologlcal controversles and unmet needs
  Chairpersons: Kostas Boboridis (Thessanoliki), Co/in Dayan (Cardiff)
11:20 - 11:40 EUGOGO consensus on eye motility assessment - Nicola Curro (Milan)
11:40 - 12:00 Assessment of primary and secondary outcomes of immunosuppressive treatment of active GO - Luigi Bartalena (Varese)
12:00 - 12:40 DEBATE: ls CAS always a reliable tool to define GO activity?
  Pro: Lucy Clark (Newcastle upon Tyne)
  Cons: Peter Dolman (Vancouver) 
12:40 - 14:15 Lunch and  Poster viewing
14:15 - 15:35 Symposium 5: from pathogenesis to medical treatment: focus on the TSH receptor
  Chairpersons: George Kahaly (Mainz),  Terry Smith (Ann Arbour)
14:15 - 14:35 TSH receptor and signaling pathways - Gerd Krause (Berlin)
14:35 - 14:55 TSH receptor and lgF-1 receptor interactions - Marvin Gershengorn (Bethesda)
14:55 - 15.15  Small molecules antagonists as potential new agents for therapeutic targeting of the TSH receptor - Susanne Neumann (Bethesda)
15:15 - 15:35 TSH receptor monoclonal blocking antibodies - Wisia Furmaniak (Cardiff)
15:40 - 16:40 Symposium 6 (Part 1 ): old and novel treatment modalltles
  Chairpersons: Mario Sa/vi (Milan),  Nichole Fichter (O/ten)
15:40 - 16:00  lntravenous glucocorticoids - C/audio Marcocci (Pisa) 
16:00 - 16:20 Selenium - Michele Marino (Pisa)
16:20 - 16:40 Mycophenolate (The MINGO Study) - George Kahaly (Mainz)
16:40 - 17:00 Coffee Break
17:00 - 18:35 Symposium 6 (Part 2): Old and novel treatment modallties
  Chairpersons: Simon Pearce (Newcastle upon Tyne), Anja Eckstein (Essen) 
17:00 - 17:20 Combined immunosuppression and radiotherapy (The CIRTED study) Peter N. Taylor (Cardiff)
17:20 - 17:40 Teprotumumab - Ray Douglas (Los Angeles)
17:40 - 18:00 Rituximab and other B cell targeting options - Mario Salvi (Milano) 
18:00 - 18:20 Tocilizumab - Jose V.  Perez-Moreiras (Santiago de Compostela)
18:20 - 18:50 lnteractive Discussion on Symposium 6
  Chairmen:  Luigi Bartalena (Varese)
18:20 - 18:25 Chairperson's summary
18:25 - 18:50 lnteractive discussion
20:30 - 23:30 Network Dinner
   
   
  SCIENTIFIC  PROGRAM Saturday, November the 9th, 2019
8:30 - 9:50 Symposium 7: ophthalmic perspectives
  Chairpersons: Marco Nardi (Pisa),  Peter Dolman (Vancouver)
8:30 - 8:50 Orbital decompression: does the approach matter? A review of the literature - Christoph Hintschich (Munich)
8:50 - 9:10 Outcome measures for strabismus surgery - Branislav Stancovic (Be/grade)
9:10 - 9:30 Treatment of eyelids and tear film alteration in GO - Kostas Boboridis (Thessaloniki)
9:30 - 9:50  Nanotechnology applied to Graves' Orbitopathy: a potential alternative to more invasive medical and surgical treatments - Djon Paridaens (Rotterdam) 
9:55 - 10:55 Oral Presentations 3
  Chairpersons: Goksun Ayvaz (Ankara),  Antonella Boschi (Brussels) Coffee  Break
10:55 . 11:15 Coffee  Break
11:15 - 12:05 Patient Forum
  Chairpersons: Dan Morris (Cardiff), Petros Perros (Newcastle upon Tyne)
11:15 - 12:05 The quality of life in GO and the impact of GO in public health - Katharina Ponto (Mainz)
11:35 - 11:55 My life with GO - Janis Hickey (British Thyroid Foundation)
11:55 - 12:15 lmplementing change for improving the care of patients with GO: the TEAMED paradigm - Co/in Dayan (Cardiff)
12:15 - 12:35 Lecture
  Chairperson: Wilmar Wiersinga (Amsterdam)
  Quo vadis GO? - Marius Stan (USA)
12:40 - 1:00 Closing Ceremony

 

Veranstaltungsort:
Camera di Commercio di Pisa

Anschrift:
Piazza Vittorio Emanuele II 5
56125 Pisa, Italien
Veranstalter:
European Group on Graves` Orbitopathy (EUGOGO)
Organisation:

A.I.C. Asti lncentives & Congressi 
Piazza San Uomobono 30 
56126 Pisa
Phone: +39 050 598808 
Fax: +39 050 0987825


Organizer : 

European Group on Graves` Orbitopathy (EUGOGO)
Endocrine Unit, Department of Medical Sciences
University of Milan
Via Sforza 35
Secretary Dr. Mario Salvi

 
Hinweis:

Please contact A.I.C. Asti lncentives & Congressi for futher information.